Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure
By Labor Department, Employee Benefits Security Administration · Nov 1, 2026, 11:00 PM CST
The Department is issuing a final regulation that will require providers of pharmacy benefit management services and affiliated providers of brokerage and consulting services to disclose information about their compensation to fiduciaries of large, self-insured group health plans subject to the Employee Retirement Income Security Act (ERISA). Pharmacy spending is a major driver of overall healthca
Excerpt shown under fair-use limits. Full text remains with the original publisher.
People in this coverage
Explore their history and attributable record. Being mentioned does not imply endorsement.
Layer 1 · Claims & fact checks
AI analysisLayer 3 · Reporting analysis
AI analysisAppeal to AuthorityThe rule is framed as fulfilling a presidential executive order, lending authority and legitimacy to the regulation.
Problem‑Solution FramingThe text presents high pharmacy costs as a problem and the disclosure requirement as the solution.
Technical LanguageUse of specific legal references positions the rule as a precise, legally grounded measure.
Context
AI analysisMissing context
The article does not provide data on how much PBM compensation currently costs employers, how the new disclosures will be implemented, or reactions from PBMs, employers, or other stakeholders.
Important context
The regulation is tied to ERISA fiduciary duties and the prohibited‑transaction exemption under section 408(b)(2), and it is linked to an executive order aimed at lowering drug prices.
Opinion vs. reporting
AI analysisThe piece primarily reports the issuance of a regulation and its intended purpose; it contains no explicit opinion, only factual description of the rule.